According to media reports, nine patients known to the Moscow eye clinic blind after using this drug.
Photo: panthermedia/vostock-photo
Moscow. September 30. INTERFAX.RU – Roszdravnadzor will check on the fact of vision loss in patients in the research Institute of eye diseases. Helmholtz in Moscow after the injection of the drug “Avastin”, reported “Interfax” on Friday the official representative of the Ministry of health Oleg Salagay.
“In connection with the advent of information about the complications in applying the drug “Avastin” in the Institute of eye diseases. Helmholtz Minister of health of Russia Veronika Skvortsova was instructed the Federal service for supervision in the sphere of healthcare is the responsibility of the Ministry of health – if) to check on this fact”, – stated in the message.
In a press-service SKR also said that check eye clinic after reports of loss of vision of nine patients.
“Investigating bodies GSU SKR across Moscow organized pre-investigation checks on the message circulated in the media, of causing patients serious injury. According to media reports nine patients one of the capital’s eye hospitals have lost sight while providing them with medical services. From the information, it also follows that a possible cause of vision loss citizens was the introduction substandard medicines”, – said the press officer.
Earlier, several media outlets reported that nine people went blind after the injection by an ophthalmologist of the drug “Avastin” in the Moscow research Institute of eye diseases. Helmholtz.
According Life.ru doctors suggest that loss of vision may be associated with the ingress of infection in the flask with the drug “Avastin”, which is used when retinal detachment. The cost of one such injection is 10 thousand rubles, and this is a cheaper analog of other similar drugs. Doctors say patients eyes react to light, but they themselves say that don’t see anything.
No comments:
Post a Comment